Genpact (NYSE:G) Trading 7.5% Higher – Should You Buy?

Shares of Genpact Limited (NYSE:G) shot up 7.5% during trading on Monday . The company traded as high as $31.14 and last traded at $31.2220. 1,842,435 shares were traded during mid-day trading, a decline of 26% from the average session volume of 2,497,019 shares. The stock had previously closed at $29.05.

Analyst Ratings Changes

G has been the topic of a number of research analyst reports. Needham & Company LLC reissued a “buy” rating and set a $50.00 price objective on shares of Genpact in a research report on Friday, May 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a research note on Friday, May 8th. Citigroup reduced their price target on shares of Genpact from $43.00 to $35.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Robert W. Baird decreased their price target on shares of Genpact from $54.00 to $45.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Finally, Wall Street Zen lowered shares of Genpact from a “buy” rating to a “hold” rating in a report on Saturday, March 14th. One investment analyst has rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Genpact has a consensus rating of “Hold” and an average target price of $43.29.

Genpact Stock Performance

The company has a 50 day moving average of $36.16 and a two-hundred day moving average of $40.95. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.69 and a quick ratio of 1.69. The company has a market capitalization of $5.31 billion, a PE ratio of 9.62, a PEG ratio of 0.83 and a beta of 0.61.

Genpact (NYSE:G) last announced its quarterly earnings data on Thursday, May 7th. The business services provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.93 by $0.05. Genpact had a return on equity of 22.70% and a net margin of 11.04%.The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the firm posted $0.84 earnings per share. The company’s revenue for the quarter was up .0% on a year-over-year basis. Genpact has set its Q2 2026 guidance at 0.960-0.970 EPS. As a group, equities research analysts predict that Genpact Limited will post 3.61 earnings per share for the current year.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be paid a dividend of $0.1875 per share. The ex-dividend date of this dividend is Wednesday, June 10th. This represents a $0.75 annualized dividend and a yield of 2.4%. Genpact’s payout ratio is presently 23.01%.

Insiders Place Their Bets

In other Genpact news, CEO Balkrishan Kalra sold 2,800 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $40.77, for a total transaction of $114,156.00. Following the completion of the transaction, the chief executive officer owned 525,007 shares of the company’s stock, valued at approximately $21,404,535.39. This trade represents a 0.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.58% of the company’s stock.

Institutional Trading of Genpact

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Royal Bank of Canada increased its position in Genpact by 19.7% during the 1st quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider’s stock valued at $6,131,000 after buying an additional 20,043 shares in the last quarter. Amundi bought a new stake in Genpact in the first quarter worth $58,000. Goldman Sachs Group Inc. grew its stake in shares of Genpact by 20.8% in the first quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider’s stock worth $17,788,000 after acquiring an additional 60,887 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Genpact by 12.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider’s stock worth $25,776,000 after acquiring an additional 56,557 shares during the last quarter. Finally, Focus Partners Wealth increased its holdings in shares of Genpact by 10.3% during the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider’s stock valued at $263,000 after acquiring an additional 488 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.

About Genpact

Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.

Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.

Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.